Trivalent COVID-19 vaccine (Sinovac)

三价新型冠状病毒疫苗（科兴生物）

Report date: 2022/09/07 11:01:18

Base Information

Drug NameTrivalent COVID-19 vaccine (Sinovac)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryChile

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSinovac Biotech Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Ltd

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A